137384-55-5 Usage
Uses
Used in Pharmaceutical Industry:
[4-(bromomethyl)cyclohexyl]methanol is utilized as a synthetic intermediate for the development of pharmaceutical compounds. Its unique structure allows for the attachment of various functional groups, facilitating the synthesis of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, [4-(bromomethyl)cyclohexyl]methanol is employed as a precursor in the synthesis of agrochemicals. Its reactivity and structural features contribute to the development of novel compounds with pesticidal or herbicidal properties, enhancing crop protection and yield.
Used in Research and Development:
[4-(bromomethyl)cyclohexyl]methanol is also used in research and development settings. It serves as a key component in the creation of new chemical entities, allowing scientists to explore innovative applications and properties of [4-(bromomethyl)cyclohexyl]methanol.
Safety Considerations:
It is crucial to handle [4-(bromomethyl)cyclohexyl]methanol with care due to the presence of a bromine atom, which can be reactive and potentially hazardous if not managed properly. Proper safety measures should be implemented during its use to minimize risks associated with its reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 137384-55-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,7,3,8 and 4 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 137384-55:
(8*1)+(7*3)+(6*7)+(5*3)+(4*8)+(3*4)+(2*5)+(1*5)=145
145 % 10 = 5
So 137384-55-5 is a valid CAS Registry Number.
137384-55-5Relevant academic research and scientific papers
PROCESS FOR PREPARING TRANEXAMIC ACID
-
Paragraph 0065; 0067; 0103-0104, (2021/06/11)
The present disclosure relates to a process for preparing tranexamic acid, the process comprising: a reacting a compound of Formula IV with at least one azidating agent to obtain a compound of Formula III, reducing the compound of Formula III to the compound of Formula I or hydrolyzing the compound of Formula III to the compound of Formula IIa, followed by reducing the compound of Formula IIa to the compound of Formula I or reducing the compound of Formula III to obtain a compound of Formula IIb, followed by hydrolyzing the compound of Formula IIb to obtain the compound of Formula I. The present disclosure also provides a single pot process for preparing Tranexamic acid of Formula I.
1,4-dihydropyridine derivatives
-
, (2008/06/13)
Compounds a formula (I) STR1 wherein the substituents and symbols have the meanings given in the specification, are new compounds with marked cardiovascular activity.
